The role of the programmed cell death protein-1/programmed death-ligand 1 pathway, regulatory T cells and T helper 17 cells in tumor immunity: a narrative review

Tumor immunotherapy, especially that involving programmed cell death protein-1 (PD-1)/programmed death-ligand 1 (PD-L1) immunosuppressive checkpoint inhibitors, has become an important part of tumor treatment strategy in the past decade. Blocking PD-1/PD-L1 signaling pathway can reduce the inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lanfang, Zhang, Mingjuan, Xu, Jinxiu, Li, Shan, Chen, Yu, Wang, Wenjing, Yang, Juntian, Li, Shengyun, Gu, Meiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729304/
https://www.ncbi.nlm.nih.gov/pubmed/33313271
http://dx.doi.org/10.21037/atm-20-6719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729304/
https://www.ncbi.nlm.nih.gov/pubmed/33313271
http://dx.doi.org/10.21037/atm-20-6719

Ejemplares similares